Watch PALX. Know when insiders buy.
One email the day a filing lands. Free.
PALX
Palomino Laboratories Inc.
17.00
+0.05 +0.29%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $469.8MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$5.2MNET CASH —52W 1.50 – 17.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$1.4M | −$1.4M | −450.5% | -0.06 | −$1.1M | $941K | −$2.1M | Aug 5 |
| Q1 2026 · Mar 31 | — | — | — | −$1.2M | −$1.2M | — | -0.07 | −$1.1M | $318K | −$1.4M | Aug 5 |
| Q4 2025 · Dec 31derived | — | — | — | −$743K | −$743K | — | 0.41 | −$894K | — | — | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$1.6M | −$1.8M | — | -0.54 | −$310K | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$337K | $389K | +112448.3% | 0.15 | −$84K | — | — | Aug 5 |
| Q1 2025 · Mar 31 | — | — | — | −$18K | −$985K | — | -0.44 | $3K | — | — | Aug 5 |
| Q4 2024 · Dec 31derived | — | — | — | −$4K | −$10K | — | -0.01 | −$6K | — | — | Mar 31 |
| Q3 2024 · Sep 30 | — | — | — | −$1K | −$6K | — | 0.00 | $32K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$32K | $346 | — | -0.01 | — | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$51K | −$247 | — | -0.01 | — | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | −$33K | −$33K | — | -0.01 | −$57K | — | — | Mar 28 |
| Q3 2023 · Sep 30 | — | — | — | −$43K | −$43K | — | -0.01 | — | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$2.7M | −$3.2M | — | -0.47 | −$1.3M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$6K | −$16K | — | -0.01 | −$5K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$84K | −$84K | — | -0.02 | −$79K | — | — | — | — |
Every number comes from Palomino Laboratories Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.